211
Participants
Start Date
April 23, 2012
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2017
escitalopram
Patients will be given escitalopram for the first 8 weeks of the trial. At week 8, patients who are assessed as 'responders' will continue on escitalopram until study endpoint.
aripiprazole
At Week 8, patients assessed as 'non-responders' will be given aripiprazole as an add-on treatment to escitalopram.
University of Calgary, Calgary
University of British Columbia, Vancouver
McMaster University, Hamilton
Queen's University, Kingston
University Health Network, Toronto
Centre for Addiction and Mental Health, Toronto
University of Toronto
OTHER
University of Calgary
OTHER
University of British Columbia
OTHER
McGill University
OTHER
Queen's University
OTHER
Centre for Addiction and Mental Health
OTHER
McMaster University
OTHER
University Health Network, Toronto
OTHER